1. Home
  2. ZNB vs AIDX Comparison

ZNB vs AIDX Comparison

Compare ZNB & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zeta Network Group Class A Ordinary Shares

ZNB

Zeta Network Group Class A Ordinary Shares

N/A

Current Price

$0.43

Market Cap

2.8M

ML Signal

N/A

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.18

Market Cap

2.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZNB
AIDX
Founded
2002
2000
Country
China
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
2.9M
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
ZNB
AIDX
Price
$0.43
$0.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.6M
206.0K
Earning Date
10-19-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 34.48
EPS
★ N/A
N/A
Revenue
N/A
★ $2,045,133.00
Revenue This Year
N/A
$44.20
Revenue Next Year
N/A
$95.73
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.71
52 Week Low
$0.10
$0.18
52 Week High
$9.78
$18.96

Technical Indicators

Market Signals
Indicator
ZNB
AIDX
Relative Strength Index (RSI) 35.09 30.30
Support Level $0.22 N/A
Resistance Level $1.93 $0.27
Average True Range (ATR) 0.21 0.03
MACD -0.01 0.00
Stochastic Oscillator 6.67 0.00

Price Performance

Historical Comparison
ZNB
AIDX

About ZNB Zeta Network Group Class A Ordinary Shares

Zeta Network Group consist principally of cryptocurrency mining. The company conducts business as two operating segments which comprise of consulting services and cryptocurrency mining. Majority of revenue comes from cryptocurrency mining segment.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: